We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
18 hedge funds and large institutions have $1.99M invested in CASI Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
126% more capital invested
Capital invested by funds: $883K → $1.99M (+$1.11M)
89% more call options, than puts
Call options by funds: $17K | Put options by funds: $9K
0.5% less ownership
Funds ownership: 2.59% → 2.08% (-0.5%)
5% less funds holding
Funds holding: 19 → 18 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
18
Holders Change
-1
Holders Change %
-5.26%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
5
Closed
4
Calls
$17K
Puts
$9K
Net Calls
+$8K
Net Calls Change
+$8K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$62.1K |
| 2 |
Renaissance Technologies
New York
|
+$54.4K |
| 3 |
Morgan Stanley
New York
|
+$6.51K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.88K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$255 |
Top Sellers
| 1 |
WSC
Wellington Shields & Co
New York
|
-$149K |
| 2 |
WSCM
Wellington Shields Capital Management
New York
|
-$97.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$82.9K |
| 4 |
Jane Street
New York
|
-$46.1K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$840 |
